Hypopress 0.1 mg/m or 10 mg/ml Solution for injection or infusion
PDF Leaflet Revision Date: 31 January 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Indicated for increasing blood pressure in adults with clinically significant hypotension.
Dosage (summary)
Adults: IV bolus 50-250 u03bcg; continuous infusion 0.5-6 u03bcg/kg/min.
Onset of Action / Duration
Onset: Immediate, Duration: 15-20 mins
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
Pregnancy & Breastfeeding
Safety during pregnancy and lactation not established; avoid use during breastfeeding.
Key Drug Interactions
- MAO inhibitors
- Indirect sympathomimetics
- Alpha sympathomimetics
Contraindications
- Hypersensitivity to phenylephrine
- Severe hypertension
- Peripheral vascular disease
Common side effects
- Headache
- Hypertension
- Bradycardia
Counselling Points
- Administer under supervision of trained professionals
- Monitor for signs of hypertension or bradycardia
Serious warnings
- Monitor blood pressure during treatment
- Risk of tissue necrosis with extravasation
Important Disclaimer
The Hypopress 0.1 mg/m or 10 mg/ml Solution for injection or infusion professional information leaflet below is the property of Umsebe Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
